PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 22, 2025European Journal of Endocrinology9 citationsOpen Access

The endocrine aspects of endometriosis

View Full Paper
FPFelice PetragliaSVSilvia VannucciniMDMarie‐Madeleine Dolmans

Key Points

  • Infertility is a common outcome in women with endometriosis, driven by inflammatory and endocrine factors.
  • Estrogen and progesterone imbalances contribute to the persistence of ectopic endometrial cells in endometriosis.
  • Hormonal treatments, such as progestins and GnRH analogs, provide relief by suppressing menstruation and pain.
  • Endometriosis involves multiple comorbidities, highlighting the need for a multidisciplinary treatment approach.

Abstract

Abstract Endometriosis is a chronic gynecologic disease of reproductive-age women, causing menstrual pain and infertility. Endocrine and inflammatory mechanisms drive its development, with estrogen/progesterone imbalance contributing to extrauterine implantation and persistence of ectopic endometrial cells. Chronic pain also induces stress-related disorders, worsening the quality of life. Infertility results from inflammatory, ovarian, and endometrial changes, and adverse pregnancy outcomes are reported. Diagnosis of endometriosis is clinical and imaging-based. Furthermore, gastrointestinal, urinary, or autoimmune comorbidities complicate endometriosis management. Hormonal treatments, including progestins, estro-progestins, GnRH analogs or oral antagonists, suppress menstruation and relieve pain. The relevant endocrine aspects and the systemic comorbidities make endometriosis a syndrome that requires a multidisciplinary diagnostic and therapeutic approach.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Petraglia et al. (2025) studied this question.

synapsesocial.com/papers/68d46fdc31b076d99fa6a5b4https://doi.org/10.1093/ejendo/lvaf192
Ask AI
Helpful
Bookmark
Share
View Full Paper